New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases

FHS
April 4, 2024
2:57 am

Study reviews the advancements in pharmacological treatments for neuropsychiatric syndromes in neurodegenerative disorders, discussing the complexities of managing symptoms such as depression, disinhibition, apathy, psychosis, and agitation to improve patient care.

Healthcare Outlook 2024

The healthcare sector had a flat performance in 2023 due to unique issues. Drug price regulation will be an uphill challenge for the sector this

January 10, 2024

No Increase in Major Cardiac Events With Testosterone-Replacement Therapy

CHICAGO — Testosterone-replacement therapy was noninferior to placebo in the occurrence of major adverse cardiac events among men with hypogonadism and established or high risk

June 17, 2023

Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from

February 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.